About
98.62USD-2.05 -2.04%
Closed • Updated at 13:39 GMT+00:00Market Cap$6.01B
Volume453.1K
Beta0.96
RSI48.26
Gross Margin81.32%
Mirum Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 21 2026
Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026
May 6 2026
Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 4 2026
Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis
Apr 29 2026
Mirum Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026
Apr 27 2026
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
Recent Videos

MIRM, Mirum Pharmaceuticals, Inc. stock prices historical data
May 09, 2026

Mirum Pharmaceuticals (MIRM) Stock 2026: 303% Past Returns, Revenue Growth – But Still No Profits
May 06, 2026

MIRM, Mirum Pharmaceuticals, Inc., 2026-05-04, stock prices dynamics, stock of the day
May 05, 2026

MIRM Clinical Trial: My Take on the 8-K Filing
Apr 27, 2026
Community Chat
Ask AI
Try asking
Google Übersetzer